INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,958,495 | +0.6% | 235,980 | -15.9% | 0.21% | +16.5% |
Q2 2023 | $5,922,285 | +31.5% | 280,677 | +6.2% | 0.18% | +32.8% |
Q1 2023 | $4,504,440 | +7.4% | 264,190 | +25.8% | 0.14% | +7.0% |
Q4 2022 | $4,194,941 | -48.1% | 209,957 | -38.9% | 0.13% | -36.3% |
Q1 2022 | $8,081,000 | -2.9% | 343,877 | +12.5% | 0.20% | +17.5% |
Q4 2021 | $8,326,000 | -1.4% | 305,663 | -0.3% | 0.17% | +6.9% |
Q3 2021 | $8,447,000 | -28.0% | 306,730 | -25.6% | 0.16% | -26.9% |
Q2 2021 | $11,738,000 | +6.5% | 412,453 | +27.5% | 0.22% | -6.4% |
Q1 2021 | $11,017,000 | -4.9% | 323,459 | -7.0% | 0.23% | -10.0% |
Q4 2020 | $11,584,000 | -13.1% | 347,981 | -16.1% | 0.26% | -42.5% |
Q3 2020 | $13,333,000 | +2.2% | 414,844 | -12.4% | 0.45% | -4.2% |
Q2 2020 | $13,047,000 | +101.9% | 473,765 | +17.5% | 0.47% | +35.6% |
Q1 2020 | $6,463,000 | -53.6% | 403,175 | -30.9% | 0.35% | -45.7% |
Q4 2019 | $13,939,000 | +51.7% | 583,717 | +12.0% | 0.64% | +26.7% |
Q3 2019 | $9,190,000 | +67.0% | 520,969 | +142.3% | 0.51% | +86.0% |
Q2 2019 | $5,503,000 | -17.3% | 214,980 | -6.1% | 0.27% | -23.8% |
Q1 2019 | $6,653,000 | – | 228,850 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |